
Sign up to save your podcasts
Or


Welcome back to our series on Landmark Papers in Vascular Surgery. In this episode, Jacob, Amanda, and Matt sit down with Dr. William Jordan to discuss arguably one of the most landmark papers in the field, the NASCET trial.
Dr. Jordan is the John E. Skandalakis Chair of Surgery, and Professor and Chief of the Division of Vascular Surgery and Endovascular Therapy at the Emory University School of Medicine in Atlanta, Georgia. He completed his medical degree at Emory, followed by a general surgery residency at the University of Alabama at Birmingham and a vascular surgery fellowship at Emory. He serves on the editorial board of the JVS family of publications and for several other journals. He is the immediate past president of the Society of Clinical Vascular Surgery, and among many contributions to research in vascular surgery in general, he has published extensively on the treatment of carotid disease. Dr. Jordan, thanks for your leadership of the specialty, and for joining us to discuss NASCET.
The NASCET Trial is the “North American Symptomatic Carotid Endarterectomy Trial,” originally published in the New England Journal of Medicine in 1991. Below are links to the original manuscript as well as several additional related publications:
Please share your feedback through our Listener Survey!
Follow us on Twitter: @AudibleBleeding
By Powered by the SVS4.8
113113 ratings
Welcome back to our series on Landmark Papers in Vascular Surgery. In this episode, Jacob, Amanda, and Matt sit down with Dr. William Jordan to discuss arguably one of the most landmark papers in the field, the NASCET trial.
Dr. Jordan is the John E. Skandalakis Chair of Surgery, and Professor and Chief of the Division of Vascular Surgery and Endovascular Therapy at the Emory University School of Medicine in Atlanta, Georgia. He completed his medical degree at Emory, followed by a general surgery residency at the University of Alabama at Birmingham and a vascular surgery fellowship at Emory. He serves on the editorial board of the JVS family of publications and for several other journals. He is the immediate past president of the Society of Clinical Vascular Surgery, and among many contributions to research in vascular surgery in general, he has published extensively on the treatment of carotid disease. Dr. Jordan, thanks for your leadership of the specialty, and for joining us to discuss NASCET.
The NASCET Trial is the “North American Symptomatic Carotid Endarterectomy Trial,” originally published in the New England Journal of Medicine in 1991. Below are links to the original manuscript as well as several additional related publications:
Please share your feedback through our Listener Survey!
Follow us on Twitter: @AudibleBleeding

22,037 Listeners

44,033 Listeners

32,317 Listeners

1,309 Listeners

2,457 Listeners

113,207 Listeners

57,056 Listeners

32,352 Listeners

4,855 Listeners

6,099 Listeners

998 Listeners

16,291 Listeners

11,400 Listeners

170 Listeners

0 Listeners